Alaunos Therapeutics (TCRT) Asset Utilization Ratio (2011 - 2026)

Alaunos Therapeutics has reported Asset Utilization Ratio for 14 years, with the latest figure at 0.0 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio fell 69.84% year-over-year to 0.0; the trailing twelve-month figure through Mar 2026 stood at 0.0 (down 69.84% YoY), and the FY2025 full-year result was 0.0, down 3.71% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.0, down from 0.0 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.08 in Q2 2023, with the low at 0.0 in Q4 2023.
• Historically, Asset Utilization Ratio has averaged 0.01 across 5 years, with a median of 0.0 in 2025.
• The largest YoY upside for Asset Utilization Ratio was 1418.34% in 2023 against a maximum downside of 99.18% in 2023.
• Alaunos Therapeutics' Asset Utilization Ratio stood at 0.04 in 2022, then slumped by 99.18% to 0.0 in 2023, then soared by 690.89% to 0.0 in 2024, then slumped by 47.64% to 0.0 in 2025, then declined by 17.22% to 0.0 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.0 (Q1 2026), 0.0 (Q4 2025), and 0.0 (Q3 2025), per Business Quant data.